I was looking for something else in my sent email box. I had forgotten about this. Sent 07/10/15.
From me to
Dr. Troy Rohn, Ph.D.
I came across your article on the Internet titled ; 1 Caspase Cleaved Tau in Alzheimer’s Disease: A Therapeutic Target realized. In the article it is mentioned that Intellect Neurosciences has the world wide rights to TauC3. My question to you is are you involved with Intellect in developing TauC3?
Thanks
Robert
Hi Robert,
At the time I wrote that article, I had nothing to do with the company and in fact had never heard of it. Since the publication of that article I have been approached (in the last week) to serve on their advisory board. I am considering it as I am passionate about the whole story involving the caspase cleavage of tau and the potential therapeutic potential of TauC3. Any reason why???
Troy Show quoted text -- Dr. Troy Rohn, Ph.D. Professor Department of Biological Sciences Boise State University *Boise School District Board of Trustees 208-426-2396
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.